Past Events

04/10/2016

Best Practice in Modelling and Simulation

Together with the Special Interest Group on M&S, EFSPI is organising a Webinar on Best Practice in Modelling and Simulation
24/06/2016

Biomarkers and Subgroups

Netherlands | June 2016
23/06/2015

Application of Methods for Health Technology Assessment

Joint EFSPI / BBS Meeting | June 2015, Basel
01/11/2014

Joint BBS-EFSPI Seminar on Data Sharing in Clinical Development

November 13th 2014 | For Slides follow the link: www.ceb-institute.org/bbs/
17/09/2013

Meeting Report

EFSPI/PSI Structured Benefit-Risk 17th September 2013
01/09/2013

EFSPI/PSI - Structured Benefit-Risk Assessment

September 2013 | London
05/06/2013

Health Technology Assessment - Joint BBS/EFSPI Seminar Programme

On June 4th 2013, the EFSPI and BBS organized a one day meeting on Health Technology Assessment. Over 115 attendees with various backgrounds attended this meeting.
30/11/2012

European Statistical Meeting on Subgroup Analysis

Friday 30th November 2012, Brussels - Subgroups analyses are important for a comprehensive assessment of confirmatory trials in marketing authorisation application. Indeed, the CHMP is currently preparing a guideline on this topic. This meeting aim
01/09/2012

Joint European Statistical Meeting - EFSPI/BBS/MSB - Modelling and Simulation and applications

Basel, Switzerland, 13th September 2012 Modelling and Simulation is a broad area appealing to many quantitative scientists and increasingly applied in clinical drug development. The meeting will include presentations on the role of M&S in drug devel
07/06/2012

Joint European Workshop FMS/EFSPI/DSBS: Benefit-Risk Assessment Methodology Workshop

Malmo, Sweden, 7th June 2012 An increase in the use of quantitative Benefit-Risk Assessment methods has been proposed to aid in the evaluation of new medicinal products by regulatory bodies and reimbursement committees throughout the world. This wor
03/06/2012

EFSPI/FMS/DSBS

18/11/2011

European Statistical Meeting: Advances in the Treatment of Missing Data

Brussels,18 November 2011 The treatment of missing data continues to be a challenge in the analysis of clinical trials, potentially affecting the integrity and validity of trial results if not handled appropriately. This meeting aims to bring togeth
18/11/2010

EFSPI-SFdS-B&S Joint European Statistical Meeting

Paris, 18-19 November 2010 The European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmacy and Health Group of the SFdS (“Société Française de Statistique”, French Society for Statistics) held their joint one and
24/06/2010

Joint EFSPI-BBS meeting, Basel, 24th June 2010 European Statistical Meeting on Oncology

The meeting was aimed at statisticians who have an interest in Oncology or wish to gain a greater understanding.
01/05/2010

Joint EFSPI-MHRA meeting - Statistics at the frontier of drug development

The meeting intended to provide a unique opportunity for discussion amongst industry, regulatory and academic scientists.
29/03/2010

EFSPI MHRA 2010

01/01/2010

EFSPI SFdS-B&S 2010

01/06/2009

European Statistical Meeting on Meta Analysis

This meeting was a joint venture between EFSPI and BBS
20/11/2008

European Statistical Meeting on Non-Inferiority

Verona, Italy, November 20th 2008 This meeting was a joint venture between EFSPI, BIAS and SSFA. Non-inferiority trials have been around for many years, but are still controversial. Experts from industry, academia and regulatory bodies have present
01/06/2008

Joint PSI-EFSPI Conference

Brussels, May 18th-21st, 2008 | This was a European Conference aimed at Statisticians in the Pharmaceutical Industry. Many opinion leaders from industry, academia and regulatory have spoken. The conference contained many parallel sessions to provide
25/10/1999

DIA Workshop on New ICH Guideline on Choice of Control Group in Clinical Trials

The Key Statistical Issues | Brussels November 1999
15/05/1994

Presentation on Annual DIA Meeting

Washington DC June 1994
17/09/1993

DIA Forum on European Biostatistics Guidelines

London October 1993
01/07/1993

Presentation on ISI 49th session in Florence

Florence August 1993